These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 26387434)

  • 1. Antibody persistence and serological protection among seasonal 2007 influenza A(H1N1) infected subjects: Results from the FLUREC cohort study.
    Delabre RM; Salez N; Lemaitre M; Leruez-Ville M; de Lamballerie X; Carrat F
    Vaccine; 2015 Dec; 33(49):7015-21. PubMed ID: 26387434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody levels in a cohort of pregnant women after the 2009 influenza A(H1N1) pandemic: Waning and association with self-reported severity and duration of illness.
    Tunheim G; Laake I; Robertson AH; Waalen K; Hungnes O; Naess LM; Cox RJ; Mjaaland S; Trogstad L
    Influenza Other Respir Viruses; 2019 Mar; 13(2):191-200. PubMed ID: 30536590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains.
    Luytjes W; Enouf V; Schipper M; Gijzen K; Liu WM; van der Lubben M; Meijer A; van der Werf S; Soethout EC
    Vaccine; 2012 Jul; 30(35):5262-9. PubMed ID: 22691431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
    Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
    Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A survey of levels of antibodies against influenza viruses in the population of Wuxi City].
    You FX; Sun N; Ma GY; Wang MM; Sa D; Shi C; Wu JL; Lin X; Xiao Y; Qian YH; Jiang Y; Xie J; Ji YY; Guan HX
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Oct; 25(5):351-4. PubMed ID: 22338222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host immune response to A(H1N1)pdm09 vaccination and infection: a one-year prospective study on six cohorts of subjects.
    Liu W; Ma MJ; Tang F; He C; Zhang XA; Jiang LF; Xin DS; Hu CY; Looman C; Cao WC
    Vaccine; 2012 Jul; 30(32):4785-9. PubMed ID: 22633868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
    Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
    HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-vaccination immunity and immune responses to a cell culture-derived whole-virus H1N1 vaccine are similar to a seasonal influenza vaccine.
    Ehrlich HJ; Müller M; Kollaritsch H; Pinl F; Schmitt B; Zeitlinger M; Loew-Baselli A; Kreil TR; Kistner O; Portsmouth D; Fritsch S; Maritsch F; Aichinger G; Pavlova BG; Barrett PN
    Vaccine; 2012 Jun; 30(30):4543-51. PubMed ID: 22475864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunity against influenza A(H1N1) infections is determined by age at the time of initial strain circulation.
    Delabre RM; Salez N; Lapidus N; Lemaitre M; Leruez-Ville M; de Lamballerie X; Carrat F
    Epidemiol Infect; 2017 Jan; 145(1):141-147. PubMed ID: 27682472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
    Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
    Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemagglutination inhibiting antibodies and protection against seasonal and pandemic influenza infection.
    Fox A; Mai le Q; Thanh le T; Wolbers M; Le Khanh Hang N; Thai PQ; Thi Thu Yen N; Minh Hoa le N; Bryant JE; Duong TN; Thoang DD; Barr IG; Wertheim H; Farrar J; Hien NT; Horby P
    J Infect; 2015 Feb; 70(2):187-96. PubMed ID: 25224643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of antibody response to the human pandemic influenza H1N1 2009 among patients with influenza-like illness and high risk groups.
    Makkoch J; Payungporn S; Prachayangprecha S; Tantilertcharoen R; Poovorawan Y
    Asian Pac J Allergy Immunol; 2010 Mar; 28(1):67-75. PubMed ID: 20527519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of prior infection and repeated vaccination on post-vaccination antibody titers of the influenza A(H1N1)pdm09 strain in Taiwan schoolchildren: Implications for public health.
    Liu W; Lien YH; Lee PI; Chan TC; Wang LC; Yang CR; Ho MS; Chen JR; Ku CC; King CC
    Vaccine; 2022 May; 40(24):3402-3411. PubMed ID: 35525727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-reactive antibody response to the pandemic A (H1N1) 2009 influenza virus induced by vaccination with a seasonal trivalent influenza vaccine: a longitudinal study of three influenza seasons in Japan.
    Uno S; Kimachi K; Matsuo F; Miyazaki K; Oohama A; Kei J; Nishimura T; Odoh K; Kino Y
    Microbiol Immunol; 2012 Dec; 56(12):810-6. PubMed ID: 23009167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cross-protection to new drifted influenza A(H3) viruses and prevalence of protective antibodies to seasonal influenza, during 2014 in Portugal.
    Guiomar R; Pereira da Silva S; Conde P; Cristóvão P; Maia AC; Pechirra P; Rodrigues AP; Nunes B; ; Milho L; Coelho AP; Fernandes A; Caseiro P; Rodrigues F; Correia L; Pereira-Vaz J; Almeida S; Branquinho P; Côrte-Real R; Viseu R; Peres MJ; Sanches R; Dantas F; Freitas L; Andrade G; Maurílio M; Caldeira F; Cabral Veloso R; Mota-Vieira L; Soares M; Couto AR; Bruges-Armas J; Pinto RM; Sobrinho Simões J; Costa MDR; Guimarães JT; Martins L; Cunha M
    Vaccine; 2017 Apr; 35(16):2092-2099. PubMed ID: 28318771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-reactive immunity against influenza viruses in children and adults following 2009 pandemic H1N1 infection.
    Ahmed MS; Jacques LC; Mahallawi W; Ferrara F; Temperton N; Upile N; Vaughan C; Sharma R; Beer H; Hoschler K; McNamara PS; Zhang Q
    Antiviral Res; 2015 Feb; 114():106-12. PubMed ID: 25513756
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
    Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
    Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune response to influenza A(H1N1)v in HIV-infected patients.
    Sansonetti P; Sali M; Fabbiani M; Morandi M; Martucci R; Danesh A; Delogu G; Bermejo-Martin JF; Sanguinetti M; Kelvin D; Cauda R; Fadda G; Rubino S
    J Infect Dev Ctries; 2014 Jan; 8(1):101-9. PubMed ID: 24423719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Herd immunity against new influenza A (H1N1) in pre-vaccinated residents aged over 5 years in Beijing].
    Lu L; Liu DL; Zhang TG; Chen M; Zhang ZJ; Wang XL; Yang Z; Pang XH; Deng Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jun; 33(6):403-5. PubMed ID: 20979808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.